由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
相关主题
Game Changer: Novavax VLP Flu Vaccines (NASDAQ:NVAX) (zt)INO
【主贴】SVA: Sinovac Biotech (Chinese Vaccine Company)VICL
SVA瀑布,出什么消息了?关于HEB,DNA,RNA药物和其它
大家一起寻宝:February 8-9,The 12th Annual BIO CEO & InvestForbes article. ILMN,LIFE,PACB,GNOM, which one will you go for?
板上懂医药的多,有大牛关注INO吗?
11月16日关注加州实验室宣布找到了治疗冠状病毒的疫苗
胖子最近作空亏惨了,呵呵Vaccination Link To H3N2 Death Cluster In Japan Hospital? (转载)
法国60万人受流感疫情波及 下周将达到高峰Vaccination Link To H3N2 Death Cluster In Japan Hospital? (转载)
相关话题的讨论汇总
话题: vaccine话题: inovio话题: dna话题: congress话题: april
1 (共1页)
h***l
发帖数: 244
1
Inovio Biomedical to Present at World Vaccine Congress 2010
Press Release Source: Inovio Biomedical Corporation On Wednesday April 14,
2010, 6:30 am EDT
BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex:
INO), a leader in DNA vaccine design, development and delivery, announced
today that the company will be presenting its DNA vaccine technology
platform and the development of universal influenza vaccine candidates at
the upcoming World Vaccine Congress to be held in Washington, DC from April
19-22.
Dr. J. Joseph Kim, Inovio President and CEO, is speaking at a panel session
on April 20th at 17:15 titled “What’s on the Horizon for DNA Vaccines?
Renewing the Promise.” The session will focus on the advancements made in
translating the potential of DNA vaccines into the clinic as well as the
potential benefits of DNA vaccines vis-à-vis other vaccine platforms in
reducing vaccine development times.
“Inovio recently announced interim data from its ongoing cervical cancer
therapy trial demonstrating the induction of strong levels of antigen-
specific, dose-related antibody and cellular immune responses. We look
forward to discussing these results at this important vaccine conference,”
noted Dr. Kim.
Dr. Niranjan Y. Sardesai, Inovio Senior VP Research and Development, is
speaking in a session on April 20th called “H1N1 Federal Planning and
Preparedness and Industry Response to Federal Strategies.” His presentation
, scheduled for 14:40, is titled “Designing DNA-based Vaccines with the
Capability to Provide Universal Protection against Unmatched Influenza Virus
Strains.” The presentation will highlight the ability of Inovio’s SynCon&
#8482; technology to side-step current “catch-up” strategies for providing
protection against influenza by designing and evaluating broadly cross-
protective DNA vaccine candidates against multiple influenza virus sub-types.
The World Vaccine Congress brings together thought leaders from the world’s
leading vaccine manufacturers, biotechs, governmental agencies, NGOs,
research and academic institutes. For more information on the Congress: http://www.terrapinn.com/2010/wvcdc/index.stm
1 (共1页)
相关主题
Vaccination Link To H3N2 Death Cluster In Japan Hospital? (转载)板上懂医药的多,
Vaccination Link To H3N2 Death Cluster In Japan Hospital?11月16日关注
Vaccination Link To H3N2 Death Cluster In Japan Hospital? (转载)胖子最近作空亏惨了,呵呵
请问打了flu shot的小娃也有可能得flu吗? (转载)法国60万人受流感疫情波及 下周将达到高峰
Game Changer: Novavax VLP Flu Vaccines (NASDAQ:NVAX) (zt)INO
【主贴】SVA: Sinovac Biotech (Chinese Vaccine Company)VICL
SVA瀑布,出什么消息了?关于HEB,DNA,RNA药物和其它
大家一起寻宝:February 8-9,The 12th Annual BIO CEO & InvestForbes article. ILMN,LIFE,PACB,GNOM, which one will you go for?
相关话题的讨论汇总
话题: vaccine话题: inovio话题: dna话题: congress话题: april